Lv5
1483 积分 2021-08-11 加入
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
1天前
待确认
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
3天前
已完结
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studies
3天前
已关闭
CDK4/6 Inhibitors in HR+/HER2- Advanced/metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies
3天前
已关闭
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
4天前
已完结
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival
10天前
已完结
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
28天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
29天前
已完结
The prognostic significance of HER2 overexpression in non-small cell lung cancer
1个月前
已关闭
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
1个月前
已完结
皖公网安备34019202002308
